Gsa Capital Partners LLP Greenwich Life Sciences, Inc. Transaction History

Gsa Capital Partners LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	BUY	$8.41 - $10.66 $104,628 - $132,621	12,441 Added 37.24%	45,850 $405,000
Q2 2023 Aug 14, 2023	BUY	$9.58 - $13.2 $198,794 - $273,913	20,751 Added 163.94%	33,409 $322,000
Q1 2023 May 12, 2023	SELL	$12.12 - $20.8 $1,454 - $2,496	-120 Reduced 0.94%	12,658 $174,000
Q4 2022 Feb 13, 2023	BUY	$9.04 - $16.88 $115,513 - $215,692	12,778 New	12,778 $194,000

1.01M

Ticker GLSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,848,200
Market Cap $173M
Description
Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who ha...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.